Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency

European Journal of Endocrinology

Volumn 167, Issue 6, 2012, Pages 769-776

  Ceccato, Filippo ^a   Albiger, Nora ^a   Reimondo, Giuseppe ^b   Frigo, Anna Chiara ^c   Ferasin, Sergio ^a   Occhi, Gianluca ^a   Mantero, Franco ^a   Terzolo, Massimo ^b   Scaroni, Carla ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; HYPERCORTISOLISM; HYPOPITUITARISM; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA ANALYSIS; SALIVA LEVEL; SALIVARY CORTISOL; SECONDARY ADRENAL INSUFFICIENCY; UNIVERSITY HOSPITAL;

ADRENAL INSUFFICIENCY; ADULT; AGED; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SALIVA;

EID: 84869058973     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0534     Document Type: Article

References (32)

1. Debono M, Price JN & Ross RJ. Novel strategies for hydrocortisone replacement. Best Practice & Research. Clinical Endocrinology & Metabolism 2009 23 221-232. (doi:10.1016/j.beem.2008.09.010)
2. Grossman AB. The diagnosis and management of central hypoadrenalism. Journal of Clinical Endocrinology and Metabolism 2010 95 4855-4863. (doi:10.1210/jc.2010-0982)
3. Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT & Ross RJ. Weight-related dosing. timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology 2004 61 367-375. (doi:10.1111/j.1365-2265.2004.02106.x)
4. Newell-Price J, Whiteman M, Rostami-Hodjegan A, Darzy K, Shalet S, Tucker GT & Ross RJ. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clinical Endocrinology 2008 68 130-135. (doi:10.1111/j.1365-2265.2007.03011.x)
5. Verma S, Vanryzin C, Sinaii N, Kim MS, Nieman LK, Ravindran S, Calis KA, Arlt W, Ross RJ & Merke DP. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clinical Endocrinology 2010 72 441-447. (doi:10.1111/j.1365-2265.2009.03636.x)
6. Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M & Beck-Peccoz P. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? Journal of Clinical Endocrinology and Metabolism 2002 87 2042-2045. (doi:10.1210/jc.87.5.2042)
7. Agha A & Monson JP. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clinical Endocrinology 2007 66 459-465. (doi:10.1111/j.1365-2265.2007.02763.x)
8. Scaroni C, Ceccato F, Rizzati S & Mantero F. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency. Journal of Endocrinological Investigation 2008 31 61-65.
9. Filipsson H & Johannsson G. GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. European Journal of Endocrinology 2009 161 S85-S95. (doi:10.1530/EJE-09-0319)
10. Monson JP. The assessment of glucocorticoid replacement therapy. Clinical Endocrinology 1997 46 269-270. (doi:10.1046/j.1365-2265.1997.87897.x)
11. Arlt W, Rosenthal C, Hahner S & Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs timed serum cortisol measurements. Clinical Endocrinology 2006 64 384-389. (doi:10.1111/j.1365-2265.2006.02473.x)
12. Garde AH & Hansen AM. Long-term stability of salivary cortisol. Scandinavian Journal of Clinical and Laboratory Investigation 2005 65 433-436. (doi:10.1080/00365510510025773)
13. Lewis JG. Steroid analysis in saliva: an overview. Clinical Biochemist. Reviews 2006 27 139-146.
14. Lederbogen F, Kühner C, Kirschbaum C, Meisinger C, Lammich J, Holle R, Krumm B, Von Lengerke T, Wichmann HE, Deuschle M et al. Salivary cortisol in a middle-aged community sample: results from 990 men and women of the KORA-F3 Augsburg study. European Journal of Endocrinology 2010 163 443-451. (doi:10.1530/EJE-10-0491)
15. Noordam R, Jansen SW, Akintola AA, Oei NY, Maier AB, Pijl H, Slagboom PE, Westendorp RG, van der Grond J, de Craen AJ et al. Familial longevity is marked by lower diurnal salivary cortisol levels: the Leiden Longevity Study. PLoS ONE 2012 7 e31166. (doi:10.1371/journal.pone.0031166)
16. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 3647-3655. (doi:10.1210/jc.2009-1166)
17. Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, Mann K & Petersenn S. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. European Journal of Endocrinology 2012 66 613-618. (doi:10.1530/EJE-11-0945)
18. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B & Quinkler M. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. European Journal of Endocrinology 2008 159 811-817. (doi:10.1530/EJE-08-0578)
19. Wong V, Yan T, Donald A & McLean M. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clinical Endocrinology 2004 61 131-137. (doi:10.1111/j.1365-2265.2004.02062.x)
20. Maguire AM, Ambler GR, Moore B, Waite K, McLean M &Cowell CT. The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism. European Journal of Endocrinology 2007 156 471-476. (doi:10.1530/EJE-06-0700)
21. Løvås K & Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology 2007 157 109-112. (doi:10.1530/EJE-07-0052)
22. Thomson AH, Devers MC, Wallace AM, Grant D, Campbell K, Freel M & Connell JM. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency. Clinical Endocrinology 2007 66 789-796. (doi:10.1111/j.1365-2265. 2007.02812.x)
23. Filipsson H, Monson JP, Koltowska-Häggström M, Mattsson A &Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism 2006 91 3954-3961. (doi:10.1210/jc.2006-0524)
24. Kraan GP, Dullaart RP, Pratt JJ, Wolthers BG, Drayer NM &De Bruin R. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. Journal of Clinical Endocrinology and Metabolism 1998 83 1247-1252. (doi:10.1210/jc.83.4. 1247)
25. Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN et al. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 4245-4253. (doi:10.1210/jc.2008- 0710)
26. Ho KK & on behalf of the GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700. (doi:10.1530/EJE-07-0631)
27. Friedrich N, Alte D, Volzke H, Spilcke-Liss E, Ludemann J, Lerch MM, Kohlmann T, Nauck M & Wallaschofski H. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population results of the Study of Health in Pomerania (SHIP). Growth Hormone & IGF Research 2008 18 228-237. (doi:10.1016/j.ghir.2007.09.005)
28. Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Current Opinion in Cardiology 2008 23 591-598. (doi:10.1097/HCO.0b013e328313133a)
29. Sawyer M & Ratain MJ. Body surface area as a determinant of pharmacokinetics and drug dosing. Investigational New Drugs 2001 19 171-177. (doi:10.1023/A:1010639201787)
30. Pruessner JC, Kirschbaum C, Meinlschmid G & Hellhammer DH. Two formulas for computation of the area under the curverepresent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003 28 916-931. (doi:10.1016/S0306-4530(02)00108-7)
31. Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. Journal of Clinical Endocrinology and Metabolism 2012 97 473-481. (doi:10.1210/jc.2011-1926)
32. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)